Literature DB >> 240179

Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients.

T Kolakowska, D H Wiles, A S McNeilly, M G Gelder.   

Abstract

Plasma levels of chlorpromazine (CPZ) and prolactin were measured repeatedly in 14 psychiatric patients throughout CPZ treatment. Mean prolactin level was elevated in 11 subjects (all six women and five of eight men). Mean plasma prolactin correlated significantly with mean plasma CPZ but not with the dose of the drug. Only patients with mean plasma prolactin above 35 ng/ml developed Parkinsonian side-effects.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 240179     DOI: 10.1017/s0033291700056488

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  8 in total

1.  Relationship between prolactin response and antipsychotic effect of thioridazine in psychiatric patients.

Authors:  R Ohman; R Axelsson
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

Review 2.  Neuroendocrine markers of CNS drug effects.

Authors:  E C Johnstone; I N Ferrier
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

3.  Relationship of butaperazine blood levels to plasma prolactin in chronic schizophrenic patients.

Authors:  R C Smith; C A Tamminga; J W Crayton; H Dekirmenjian; J M Davis
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

4.  Variability of prolactin response to intravenous and intramuscular haloperidol in normal adult men.

Authors:  R T Rubin; S E Hays
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

5.  Effect of sulpiride on monoaminergic mechanisms in psychotic women.

Authors:  L Bjerkenstedt; C Härnryd; G Sedval
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

6.  Plasma levels of fluphenazine and prolactin in psychiatric patients.

Authors:  T Kitamura; D A McGovern; N W Imlah; D Wiles; A A Schiff
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988-09

7.  Plasma fluphenazine and prolactin levels in schizophrenic patients during treatment with low and high doses of fluphenazine enanthate.

Authors:  D Wiles; M Franklin; S J Dencker; R Johansson; L Lundin; U Malm
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

8.  Prediction of new drug indications based on clinical data and network modularity.

Authors:  Liang Yu; Xiaoke Ma; Long Zhang; Jing Zhang; Lin Gao
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.